| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides.
|
Clin Diagn Lab Immunol
|
2003
|
3.27
|
|
2
|
Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants.
|
Vaccine
|
2003
|
2.87
|
|
3
|
The fundamental link between pneumococcal carriage and disease.
|
Expert Rev Vaccines
|
2012
|
2.79
|
|
4
|
Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.
|
Clin Infect Dis
|
2003
|
1.94
|
|
5
|
Quantitative and qualitative anamnestic immune responses to pneumococcal conjugate vaccine in HIV-infected and HIV-uninfected children 5 years after vaccination.
|
J Infect Dis
|
2009
|
1.82
|
|
6
|
Immunogenicity and reactogenicity of 23-valent pneumococcal polysaccharide vaccine among pregnant Filipino women and placental transfer of antibodies.
|
Vaccine
|
2007
|
1.63
|
|
7
|
Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants.
|
J Infect Dis
|
2010
|
1.39
|
|
8
|
Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae.
|
Clin Diagn Lab Immunol
|
2003
|
1.38
|
|
9
|
Streptococcus pneumoniae capsular serotype 19F is more resistant to C3 deposition and less sensitive to opsonophagocytosis than serotype 6B.
|
Infect Immun
|
2008
|
1.33
|
|
10
|
Quantitative and qualitative antibody response to pneumococcal conjugate vaccine among African human immunodeficiency virus-infected and uninfected children.
|
Pediatr Infect Dis J
|
2005
|
1.31
|
|
11
|
Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccines.
|
Clin Vaccine Immunol
|
2009
|
1.25
|
|
12
|
Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins.
|
Clin Vaccine Immunol
|
2008
|
1.24
|
|
13
|
Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial.
|
Infect Immun
|
2005
|
1.21
|
|
14
|
Development of natural antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A and pneumolysin in Filipino pregnant women and their infants in relation to pneumococcal carriage.
|
Vaccine
|
2005
|
1.17
|
|
15
|
Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosis.
|
Vaccine
|
2011
|
1.12
|
|
16
|
Development of antibodies against pneumococcal proteins alpha-enolase, immunoglobulin A1 protease, streptococcal lipoprotein rotamase A, and putative proteinase maturation protein A in relation to pneumococcal carriage and Otitis Media.
|
Vaccine
|
2004
|
1.09
|
|
17
|
Specificities and opsonophagocytic activities of antibodies to pneumococcal capsular polysaccharides in sera of unimmunized young children.
|
Clin Diagn Lab Immunol
|
2002
|
1.08
|
|
18
|
Protection by natural human immunoglobulin M antibody to meningococcal serogroup B capsular polysaccharide in the infant rat protection assay is independent of complement-mediated bacterial lysis.
|
Infect Immun
|
2005
|
1.06
|
|
19
|
Immunogenicity and effectiveness of Haemophilus influenzae type b conjugate vaccine in HIV infected and uninfected African children.
|
Vaccine
|
2005
|
1.06
|
|
20
|
Long term effects of vaccination of patients deficient in a late complement component with a tetravalent meningococcal polysaccharide vaccine.
|
Vaccine
|
2003
|
1.05
|
|
21
|
The capsular serotype of Streptococcus pneumoniae is more important than the genetic background for resistance to complement.
|
Infect Immun
|
2010
|
1.05
|
|
22
|
Interaction of pneumococcal histidine triad proteins with human complement.
|
Infect Immun
|
2010
|
1.05
|
|
23
|
Pneumococcal carriage and acute otitis media induce serum antibodies to pneumococcal surface proteins CbpA and PhtD in children.
|
Vaccine
|
2009
|
1.03
|
|
24
|
Anti-PsaA and the risk of pneumococcal AOM and carriage.
|
Vaccine
|
2003
|
1.01
|
|
25
|
Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial.
|
Infect Immun
|
2007
|
1.01
|
|
26
|
Immunogenicity and safety of the eleven valent pneumococcal polysaccharide-protein D conjugate vaccine in infants.
|
Pediatr Infect Dis J
|
2004
|
1.01
|
|
27
|
Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal capsular polysaccharides in children.
|
J Infect Dis
|
2002
|
1.00
|
|
28
|
Multilaboratory comparison of Streptococcus pneumoniae opsonophagocytic killing assays and their level of agreement for the determination of functional antibody activity in human reference sera.
|
Clin Vaccine Immunol
|
2010
|
0.99
|
|
29
|
Antibodies to pneumococcal proteins PhtD, CbpA, and LytC in Filipino pregnant women and their infants in relation to pneumococcal carriage.
|
Clin Vaccine Immunol
|
2009
|
0.99
|
|
30
|
Serotype-specific hyporesponsiveness to pneumococcal conjugate vaccine in infants carrying pneumococcus at the time of vaccination.
|
J Pediatr
|
2010
|
0.98
|
|
31
|
Evolution of conjugate vaccines.
|
Expert Rev Vaccines
|
2002
|
0.98
|
|
32
|
Impact of the conjugation method on the immunogenicity of Streptococcus pneumoniae serotype 19F polysaccharide in conjugate vaccines.
|
Clin Vaccine Immunol
|
2010
|
0.98
|
|
33
|
Long-term persistence of immunity after immunisation with Haemophilus influenzae type b conjugate vaccine.
|
Vaccine
|
2003
|
0.95
|
|
34
|
Serotype-related variation in susceptibility to complement deposition and opsonophagocytosis among clinical isolates of Streptococcus pneumoniae.
|
Infect Immun
|
2010
|
0.93
|
|
35
|
Effects of feeding probiotics during weaning on infections and antibody responses to diphtheria, tetanus and Hib vaccines.
|
Pediatr Allergy Immunol
|
2007
|
0.93
|
|
36
|
Antibody response to pneumococcal capsular polysaccharides in children with acute otitis media.
|
Pediatr Infect Dis J
|
2002
|
0.92
|
|
37
|
Protection by meningococcal outer membrane protein PorA-specific antibodies and a serogroup B capsular polysaccharide-specific antibody in complement-sufficient and C6-deficient infant rats.
|
Infect Immun
|
2006
|
0.92
|
|
38
|
Passive protection in the infant rat protection assay by sera taken before and after vaccination of teenagers with serogroup B meningococcal outer membrane vesicle vaccines.
|
Vaccine
|
2005
|
0.91
|
|
39
|
Antibody-dependent killing of meningococci by human neutrophils in serum of late complement component-deficient patients.
|
Int Arch Allergy Immunol
|
2003
|
0.90
|
|
40
|
Antibody response to an eleven valent diphtheria- and tetanus-conjugated pneumococcal conjugate vaccine in Filipino infants.
|
Pediatr Infect Dis J
|
2002
|
0.90
|
|
41
|
Serum antibodies to the pneumococcal surface proteins PhtB and PhtE in Finnish infants and adults.
|
Pediatr Infect Dis J
|
2007
|
0.89
|
|
42
|
Functional activity of antibodies after immunization of Finnish and Israeli infants with an 11-valent pneumococcal conjugate vaccine.
|
Vaccine
|
2005
|
0.88
|
|
43
|
Serum IgM antibodies contribute to high levels of opsonophagocytic activities in toddlers immunized with a single dose of the 9-valent pneumococcal conjugate vaccine.
|
Clin Vaccine Immunol
|
2012
|
0.88
|
|
44
|
Safety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus protein--conjugated pneumococcal vaccine in Filipino infants.
|
BMC Infect Dis
|
2003
|
0.88
|
|
45
|
Functional antibodies elicited by an 11-valent diphtheria-tetanus toxoid-conjugated pneumococcal vaccine.
|
J Infect Dis
|
2003
|
0.88
|
|
46
|
Serum antibodies to pneumococcal neuraminidase NanA in relation to pneumococcal carriage and acute otitis media.
|
Clin Vaccine Immunol
|
2006
|
0.87
|
|
47
|
Mother-infant vaccination with pneumococcal polysaccharide vaccine: persistence of maternal antibodies and responses of infants to vaccination.
|
Vaccine
|
2011
|
0.87
|
|
48
|
Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines.
|
Vaccine
|
2004
|
0.86
|
|
49
|
Greater antibody responses to an eleven valent mixed carrier diphtheria- or tetanus-conjugated pneumococcal vaccine in Filipino than in Finnish or Israeli infants.
|
Pediatr Infect Dis J
|
2003
|
0.86
|
|
50
|
Safety and immunogenicity of a DTaP-IPV(Vero) (serum-free) combination vaccine in comparison to DTaP-IPV(Mkc) when administered simultaneously with Haemophilus influenzae type B conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age.
|
Vaccine
|
2008
|
0.85
|
|
51
|
Haemophilus influenzae type b conjugate vaccine diluted tenfold in diphtheria-tetanus-whole cell pertussis vaccine: a randomized trial.
|
Pediatr Infect Dis J
|
2002
|
0.85
|
|
52
|
Genotypic and phenotypic characterization of carriage and invasive disease isolates of Neisseria meningitidis in Finland.
|
J Clin Microbiol
|
2011
|
0.84
|
|
53
|
Similar antibody concentrations in Filipino infants at age 9 months, after 1 or 3 doses of an adjuvanted, 11-valent pneumococcal diphtheria/tetanus-conjugated vaccine: a randomized controlled trial.
|
J Infect Dis
|
2004
|
0.83
|
|
54
|
Association of serotype-specific antibody concentrations and functional antibody titers with subsequent pneumococcal carriage in toddlers immunized with a 9-valent pneumococcal conjugate vaccine.
|
Clin Vaccine Immunol
|
2011
|
0.82
|
|
55
|
Salivary antibodies induced by the seven-valent PncCRM conjugate vaccine in the Finnish Otitis Media Vaccine Trial.
|
Vaccine
|
2004
|
0.82
|
|
56
|
Adenoidectomy and nasopharyngeal carriage of Streptococcus pneumoniae in young children.
|
Arch Dis Child
|
2010
|
0.81
|
|
57
|
IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.
|
Vaccine
|
2009
|
0.81
|
|
58
|
Concentration and high avidity of pneumococcal antibodies persist at least 4 years after immunization with pneumococcal conjugate vaccine in infancy.
|
Clin Vaccine Immunol
|
2013
|
0.81
|
|
59
|
Salivary antibodies induced by the seven-valent PncOMPC conjugate vaccine in the Finnish Otitis Media Vaccine Trial.
|
BMC Infect Dis
|
2005
|
0.80
|
|
60
|
Haemophilus influenzae type b (Hib) antibody concentrations and vaccination responses in patients with chronic lymphocytic leukaemia: predicting factors for response.
|
Leuk Lymphoma
|
2002
|
0.80
|
|
61
|
Vaccination against infections in chronic lymphocytic leukemia.
|
Leuk Lymphoma
|
2003
|
0.80
|
|
62
|
Pneumococcal Haemophilus influenzae protein D conjugate vaccine induces antibodies that inhibit glycerophosphodiester phosphodiesterase activity of protein D.
|
Infect Immun
|
2008
|
0.78
|
|
63
|
Similar humoral immunity parameters in chronic lymphocytic leukemia patients independent of VH gene mutation status.
|
Leuk Lymphoma
|
2004
|
0.77
|
|
64
|
Adenoidectomy in young children and serum IgG antibodies to pneumococcal surface protein A and choline binding protein A.
|
Int J Pediatr Otorhinolaryngol
|
2012
|
0.76
|
|
65
|
Immunity after (re)vaccination of paediatric patients following haematopoietic stem cell transplantation.
|
Acta Paediatr
|
2012
|
0.75
|
|
66
|
Effect of Pneumococcal Conjugate Vaccine on the Natural Antibodies and Antibody Responses Against Protein Antigens From Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Children With Community-acquired Pneumonia.
|
Pediatr Infect Dis J
|
2016
|
0.75
|
|
67
|
Response and persistence of antibodies to PRP-T and DTwP vaccines with concomitant administration of conjugate vaccines.
|
Vaccine
|
2006
|
0.75
|
|
68
|
[Lack of spleen or spleen malfunction--serious risk factor for sepsis].
|
Duodecim
|
2004
|
0.75
|